These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2068837)

  • 1. Fludarabine: a review.
    Hood MA; Finley RS
    DICP; 1991 May; 25(5):518-24. PubMed ID: 2068837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
    Johnson S; Smith AG; Löffler H; Osby E; Juliusson G; Emmerich B; Wyld PJ; Hiddemann W
    Lancet; 1996 May; 347(9013):1432-8. PubMed ID: 8676625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.
    Adkins JC; Peters DH; Markham A
    Drugs; 1997 Jun; 53(6):1005-37. PubMed ID: 9179529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral fludarabine.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(21):2317-23. PubMed ID: 14524733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fludarabine as monotherapy in the treatment of chronic lymphocytic leukemia.
    Leporrier M
    Hematol J; 2004; 5 Suppl 1():S10-9. PubMed ID: 15079149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
    Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
    N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new purine analog in the treatment of hematologic malignancy. I. Fludarabine].
    Vásová I; Penka M; Hájek R; Mayer J; Krahulcová E
    Vnitr Lek; 1997 Jan; 43(1):45-50. PubMed ID: 9221567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oral fludarabine in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Zhu Y; Qin Q; Xie Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 38(3):221-4. PubMed ID: 23545817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy.
    Weiss MA; Glenn M; Maslak P; Rahman Z; Noy A; Zelenetz A; Scheinberg DA; Golde DW
    Leukemia; 2000 Sep; 14(9):1577-82. PubMed ID: 10995003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy.
    Ross SR; McTavish D; Faulds D
    Drugs; 1993 May; 45(5):737-59. PubMed ID: 7686467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic myelogenous leukemia with nucleoside analogs deoxycoformycin and fludarabine.
    Cortes J; Kantarjian H; Talpaz M; O'Brien S; Beran M; Koller C; Keating M
    Leukemia; 1997 Jun; 11(6):788-91. PubMed ID: 9177428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia.
    Hocepied AM; Falkson CI; Falkson G
    S Afr Med J; 1996 May; 86(5):549-50. PubMed ID: 8711555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia.
    Kantarjian HM; Childs C; O'Brien S; Huh Y; Beran M; Schachner J; Koller C; Keating MJ
    Am J Med; 1991 Feb; 90(2):223-8. PubMed ID: 1996592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludarabine for treatment of adult acute myelogenous leukemia.
    Gandhi V
    Leuk Lymphoma; 1993; 11 Suppl 2():7-13. PubMed ID: 8124234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term results with fludarabine monotherapy in chronic lymphocytic leukemia].
    Varga F; Lehoczky D; Demeter J
    Orv Hetil; 1999 Aug; 140(31):1731-5. PubMed ID: 10463032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma.
    Keating MJ; McLaughlin P; Plunkett W; Robertson LE; O'Brien S; Gandhi V; Gregoire V; Yang L; Cabanillas F
    Ann Oncol; 1994; 5 Suppl 2():79-83. PubMed ID: 8204523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
    Martell RE; Peterson BL; Cohen HJ; Petros WP; Rai KR; Morrison VA; Elias L; Shepherd L; Hines J; Larson RA; Schiffer CA; Hurwitz HI
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):37-45. PubMed ID: 12111110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with fludarabine in leukaemia.
    Keating MJ; Estey E; O'Brien S; Kantarjian H; Robertson LE; Plunkett W
    Drugs; 1994; 47 Suppl 6():39-49. PubMed ID: 7525188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
    Chun HG; Leyland-Jones B; Cheson BD
    J Clin Oncol; 1991 Jan; 9(1):175-88. PubMed ID: 1702143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.